Ellume is a digital diagnostics company that develops and commercializes accurate, connected products for healthcare professionals and consumers.

We focus on the detection of common illnesses that affect the global population. Our products differ from conventional diagnostics through a digitally enabled link to treatment.


We have developed a new biosensor technology which features unique optoelectronics and biologics. Our novel quantum dot platform makes this technology usable for the detection of many illnesses.

Recent News

Ellume Appoints CFO And CBO

  • Posted by Ellume
  • On April 23, 2019
Brisbane, Australia – 23rd April 2019 Ellume Limited (Ellume) is pleased to announce the appointment of David Green as Chief Financial Officer and Company Secretary, and Mark Boyle Chief Business Officer of the Company. These appointments strengthen the management of the company in preparation for US commercialisation and potential ASX IPO later this year. David […]
Read More